Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Astellas Pharma Inc
YPHCurrent price
10.59 EUR
0 EUR (0.00%)
Last closed
10.29 EUR
Company
www.astellas.com
ISIN
JP3942400007
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
Stuttgart Exchange
Capitalization
19 262 210 470 EUR
Yield for 12 month
-18.44 %
1Y
3Y
5Y
10Y
15Y
YPH
Astellas Pharma Inc. manufactures, markets, and imports and exports pharmaceuticals in Japan and internationally. The company provides XTANDI, a treatment for prostate cancer; XOSPATA, a treatment for patients who have relapsed or refractory acute myeloid leukemia with a FLT3 mutation; and PADCEV, a treatment for patients with metastatic urothelial cancer. It also offers Evrenzo, a treatment for anemia associated with chronic kidney disease; Betanis/Myrabetriq/BETMIGA, a treatment for overactive bladder; and Prograf and Advagraf/Graceptor/ASTAGRAF XL immunosuppressants. Th company has a research collaboration with Vivtex Corporation to evaluate Vivtex's GI-ORIS screening and formulation platform technology to support the development of novel and oral versions of a therapeutic candidate provided by Astellas; and a partnership agreement with Roche Diabetes Care Japan Co., Ltd. to develop and commercialize integrated diabetes self-management solution. The company was founded in 1923 and is headquartered in Tokyo, Japan. Address: 2-5-1, Nihonbashi-Honcho, Tokyo, Japan, 103-8411
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
–P/E ratio
128.625Dividend Yield
4.41 %Current Year
+9 821 914 624 EUR
Last Year
+9 300 995 568 EUR
Current Quarter
+2 539 288 238 EUR
Last Quarter
+2 584 181 853 EUR
Current Year
+8 030 549 121 EUR
Last Year
+7 534 937 079 EUR
Current Quarter
+2 090 786 932 EUR
Last Quarter
+2 119 340 007 EUR
Key Figures YPH
1 year
3 years
5 years
10 years
EBITDA
279 950 871 236 EUR
Operating Margin TTM
PE Ratio
128.625
Return On Assets TTM
1.82 %
PEG Ratio
–
Return On Equity TTM
1.32 %
Wall Street Target Price
–
Revenue TTM
1 701 574 234 006 EUR
Book Value
936.11 EUR
Revenue Per Share TTM
Dividend Share
69.99 EUR
Quarterly Revenue Growth YOY
26.2 %
Dividend Yield
4.41 %
Gross Profit TTM
1 043 011 965 976 EUR
Earnings per share
0.08 EUR
Diluted Eps TTM
0.08 EUR
Most Recent Quarter
I 2024
Quarterly Earnings Growth YOY
13.7 %
Profit Margin
1.26 %
Dividend Analytics YPH
Champion
- 10+ consecutive years of dividend increases
Dividend growth over 5 years
76 %Continuous growth
10 yearsPayout Ratio 5 years average
66 %Dividend History YPH
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
0.45
Ex Dividend Date
28.03.2025
Forward Annual Dividend Yield
4.41 %
Last Split Factor
5:1
Payout Ratio
583.82 %
Last Split Date
27.03.2014
Dividend Date
–
Stock Valuation YPH
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
128.625
Forward PE
12.3457
Enterprise Value Revenue
2.0928
Price Sales TTM
0.0113
Enterprise Value EBITDA
15.6721
Price Book MRQ
1.7978
Financials YPH
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators YPH
For 52 weeks
8.47 EUR
12.86 EUR
50 Day MA
10.5 EUR
Shares Short Prior Month
–
200 Day MA
9.81 EUR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart